Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data

Go back to Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data
(NASDAQ: BNTX) Delayed: 88.63 -1.04 (1.16%)
Previous Close $89.67    52 Week High $ 
Open $89.34    52 Week Low $ 
Day High $89.86    P/E N/A 
Day Low $87.52    EPS $ 
Volume 352,954       

Pfizer Inc. (NYSE: PFE) Delayed: 30.06 -0.36 (1.18%)
Previous Close $30.42    52 Week High $37.39 
Open $30.28    52 Week Low $28.25 
Day High $30.32    P/E 18.22 
Day Low $29.81    EPS $1.65 
Volume 12,464,200